Zantac Lawsuit


Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Showing posts with label GSK FILES. Show all posts
Showing posts with label GSK FILES. Show all posts

Tuesday, September 29, 2009

Natalie Morton, 14 Dies after Cervarix jab




The first pictures of Natalie Morton have surfaced in the British press after the 14 year old tragically died hours after being given the cervical cancer vaccine, Cervarix.

The Mail Online reports how a fellow pupil gave a dramatic account of how Natalie collapsed.

The 15-year-old girl said: "We all had the jab today from Year Nine to the sixth form.

About an hour after having the jab Natalie went really pale and wasn't breathing. I think it was around lunchtime.

She fainted in the corridor. I saw ambulance men pumping her chest then the teachers told us to go outside.

A lot of people were crying afterwards and we were all very worried.

We have to have three of the jabs in all and a lot of us don't want to take the rest, but they're telling us we have to because there will be sideeffects if we don't have them all."


Last night, there were calls for the entire cervical cancer vaccination programme to be suspended.

I have to say that I echo the call for the mass vaccination to be suspended until the death of this child has been fully and impartially investigated. I see no reason whatsoever why this cannot be done.

The article has provoked many comments from readers, one in particular who writes:

"Of 100+ types of HPV, only 10-30 can cause cervical cancer. The rest can lead to skin infections that cause genital or common warts on hands and feet. There's actually little cause for alarm because, in 90% cases, your body's immune system clears the HPV infection naturally within 2 years for both the wart- and cancer-forming virus.

Still, we are led to believe that getting the vaccine will protect girls from the slight risk of cervical cancer that does exist -- but this is not the case. The vaccine contains just 4 types of HPV (out of 100+ strains). If you contract one of the 96+ types that aren't included, you're out of luck. And, if you've already been exposed to one of the 4 types of virus in the vaccine, it doesn't work either.

This is all about money and profit, with no concern about true health well being."


Dr Pim Kon, medical director at GlaxoSmithKline UK, said: "Our deepest sympathies are with the family and friends of the young girl.

We are working with the Department of Health and MHRA (Medicines and Healthcare products Regulatory Agency) to better understand this case, as at this stage the exact cause of this tragic death is unknown."


Glaxo added that the vast majority of suspected adverse reactions have related either to the symptoms of recognised side effects or were due to the injection process and not the vaccine itself.

Cervarix was chosen for the NHS programme because it offered 'best overall value for the NHS'.

The NHS pays £80 a dose, plus admin and staff costs, and three jabs are given altogether.

Related Links:




GlaxoSmithKline challenged safety Cervarix anti-cancer vaccine left girl partially paralysed

4,602 Suspected Adverse Reactions to GSK's Cervarix!

Girls used as Guinea Pigs in HPV Trials Admits GSK

GSK - A Catalogue of Disasters!

Glaxo: "Promote More, Feel Better and Live a Life of Luxury"

Glaxo Goes Head-to-Head on HPV

Teenage Girls Sue Over GSK's Cancer Jab, Cervarix!

GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine

HPV Vaccine Video on Youtube

Concerns over GSK's Cervarix vaccine

UP YOURS GLAXO!

Mindy Merck & Gail Glaxo Dilemma

LOLA'S LAND PROMOTING HPV VACCINE

GlaxoSmithKline's Cervarix. Is Your Daughter Safe?

More debate on GSK's Cervarix

Cervical Cancer, Ofsted & GlaxoSmithKline

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Sunday, September 27, 2009

Big Announcement Tomorrow



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Saturday, September 26, 2009

Paxil [Seroxat] "more powerful a teratogen than cocaine"







Quite an alarming statement, wouldn't you agree? Nonetheless it comes from the opening statement in the Kilker v GlaxoSmithKline trial.

Firstly, the definition of the word, 'teratogen' is thus:

a drug or other substance capable of interfering with the development of a fetus, causing birth defects. [1]

Doctor Sloot is a European doctor who works for Shearing Plough.

The following was taken from the court transcript in the current Kilker v GlaxoSmithKline trial, currently on-going in Philadelphia, US. [2]

"In May of this year, 2009, a study was published by Doctor Sloot. The study said this.

What Doctor Sloot did is, he took Paxil and all the other reuptake inhibitors and he exposed rat fetuses to these 12 different drugs, including Paxil. And what Shearing Plough was trying to figure out, what they were trying to do was figure out whether one of the drugs that they were going to put on the market to compete with GSK's drug was capable of causing birth defects. And so they took the drug they were going to take to market, and before they took it to market, they did this test. And they compared it to all the other SSRIs. Because, as you will learn, GSK never did this test.

What Doctor Sloot discovered in May of this year is that out of all the teratogen, out of all the SSRIs, the 12, only one was a clear teratogen, Paxil. He discovered that Paxil in May of this year was actually more powerful a teratogen than cocaine.

It would be safer, according to Doctor Sloot's study, to take cocaine than it would be to take Paxil while you were pregnant.

Now, Shearing Plough, quite rightly, took their drug that they were thinking about taking to market to compete with Paxil, and even though it was just a possible teratogen, they scrapped their plans to take it to market and decided the risk was not worth the benefit."


More revelations can be found if you read the documents for yourselves. For the record, GlaxoSmithKline's arguments are featured in the documents and it is up to the reader to decide fact from fiction. The documents are now in the public domain and will no doubt cause much debate.


[1] http://dictionary.reference.com/browse/teratogen

[2]
9/15/09 AM: Opening Statements

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Friday, September 25, 2009

MARTIN B KELLER TO BE HONOURED




Does anyone have a cure for bile?


I have sick in my mouth after reading this.




The Department of Psychiatry and Human Behavior & Butler Hospital & The Alpert Medical School of Brown University.

invite you to a

Festschrift in Honor of Martin B. Keller, MD

Thursday, October 8, 2009 • 1:00 - 5:00 pm

Ray Conference Center • Butler Hospital Campus

Distinguished Speakers

Robert Hirschfeld, MD
“Diagnosis and Clinical Course of Mood Disorders: The NIMH Collaborative Study on the Psychobiology of Depression”

Lewis Judd, MD
“Longitudinal Course of Bipolar Disorders and Treatment Implications”

Katharine Phillips, MD
“Body Dysmorphic Disorder”

Alan Schatzberg, MD
“Putting Chronic Depression on the Clinical Map”

Myrna Weissman, MD
“Three Generations at Risk for Depression”



RSVP Required to attend.

Please email DPHB@Brown.edu for more information on how to RSVP to this event.

For Directions to Ray Conference Center at Butler Hospital Campus: http://www.butler.org/body.cfm?id=33

PDF File here

Read more about Keller HERE

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Kilker v GlaxoSmithKline - Raises questions about Charles Nemeroff

For full transcript refer to earlier post here. This particular segment comes from the direct and cross examination of David Healy.

Apologies in advance for the poor formatting of this post.

Mr Tracey is Attorney for the plaintiffs [Kilker's]

Ms Chilton is Attorney for the defendants [GlaxoSmithKline]


(Jury enters courtroom at 2:05 p.m.)


BY MR. TRACEY:

Q. Dr. Healy, who's Dr. Charles Nemeroff?

A. Dr. Charles Nemeroff was the Chief of Psychiatry from University of Emory down in Georgia.

Q. He is a psychiatrist?

A. He is. He's possibly best known or was the best known psychiatrist in the United States.

Q. Was he an influential psychiatrist?

A. Extremely influential.

Q. Who did he influence?

13 A. He influenced an awful lot of heads of departments, professors of psychiatry, general people within the field of academic mental health, and through them and an awful lot of prescribing doctors here in the U.S. And, indeed, perhaps worldwide.

Q. Was he the kind of doctor that if people wanted to know something about psychiatry, they looked up what he wrote so they could get his opinions?

A. His views would have been extremely influential.

Q. Was he on the GlaxoSmithKline advisory board?

A. Yes, he was. He was there from the start.

Q. Was he one of the founding members of the Paxil advisory board?

A. He was, I believe.

Q. Did he get paid for all of this?

A. He did.

Q. Did he do CMEs on Paxil?

A. He was involved -- he would have been the key person in producing the kinds of talks with slides that would have been held for large audiences of doctors, and then those slides and talks would have been distributed out to different doctors in the field who hadn't been at the major meetings as he gave his talk.

Q. Doctor, if you will turn to, I think, it's Tab 19.

MR. TRACEY: This is Plaintiff's Exhibit 337, if there is no objection.

MS. CHILTON: Same objection as before, Your Honor.

THE COURT: Overruled.

BY MR. TRACEY:

Q. Is Dr. Nemeroff here M.D., Ph.D, the Reunette Harris Professor and Chair Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia?

A. Yes.

Q. You actually know Dr. Nemeroff, don't you?

A. Yes.

Q. You talked to him and met him at meetings?

A. Over a 20-odd year period we met quite often. The most recent would have been actually May this year.

Q. Now, as Dr. Nemeroff -- do you know whether Dr. Nemeroff is still the chairman of the Department of Psychiatry at Emory?

A. Yes, I do know.

Q. Is he?

A. No, he is not.

Q. When did he lose the position?

A. He lost the position in the course of the last year.

Q. This particular document it says up top a CME.

Q. What is a CME?

A. That stands for continuing medical education.

Q. This is where doctors will go to hear other doctors speak on topics relevant to their practice?

A. That's correct.

Q. And the name of this document or this CME is Fertility, Mood and Motherhood?

A. That's correct.

Q. Do we know, in looking at the document, whether there was any GSK involvement in the material?

A. We do know that this material was prepared for Dr. Nemeroff, yes.

Q. By GSK?

A. Yes; and through them, agencies like STI, for instance.

Q. When I look at the -- when I actually look at the document, it's about 15 pages long, is there a place to put in this document, in this CME who were the people that wrote it or put it together or did the slides?

A. No, I think most doctors looking at this would assume it was prepared by Dr. Nemeroff.

Q. All right. If you can turn to Tab 23.

MR. TRACEY: This is Plaintiff's Exhibit 1661, Your Honor, which plaintiffs
will move to admit.

THE COURT: Wait a second, please. Going back to the other document for a second, sir, the last page, does not the document indicate that it was supported through an unrestricted educational grant from SmithKline Beecham Pharmaceutical?

THE WITNESS: Yes, it does.

THE COURT: Go to your next questions.

BY MR. TRACEY:

Q. That's on the last page of that document, Doctor, right?

A. Yes.

Q. To be clear, the last page of the document says that the materials were provided by SmithKline Beecham.

A. No, it says supported by unrestricted educational grant. That Dr. Nemeroff was reimbursed for his role in this.

Q. I see; okay.


----

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Thursday, September 24, 2009

**EXCLUSIVE - KILKER v GLAXOSMITHKLINE COURT DOCUMENTS

"Now, this particular type of drug we talked about during jury selection a little bit. It is called the selective serotonin reuptake inhibitor. That is actually a name that GlaxoSmithKline coined. They coined that phrase. You are going to learn they coined it because Paxil is the most selective, the most powerful of the serotonin reuptake inhibitors."


The documents are located on the Baum, Hedlund, Aristei & Goldman web page.


In the Court of Common Pleas, First Judicial District of Pennsylvania, Civil Trial Division

LYAM KILKER, a Minor, by MICHELLE M. DAVID, as Next Friend and Individually
VS.
SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE



9/15/09 AM: Opening Statements




Plaintiff’s Expert: David Healy, MD FRCPsych, Neuropyschopharmacologist, Professor of Psychiatry, Cardiff University,University Hospital Wales North Wales Department of Psychological Medicine

9/15/09 PM: David Healy, M.D. -- Direct Examination




9/16/09 AM: David Healy, M.D. -- Direct (continued)




9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination






9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect





9/17/09 PM: David Healy, M.D. -- Recross; Redirect






Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee


9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination




9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)




Plaintiff’s Expert: Shira Kramer, Ph.D., Epidemiologist

9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination



9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect




Plaintiff’s Expert: Ra-id Abdulla, M.D.


9/23/09 AM: Ra-id Abdulla, M.D. -- Direct Examination





9/23/09 PM: Ra-id Abdulla, M.D. -- Cross Examination; Redirect



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Please contact me if you would like a guest post considered for publication on my blog.